No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs536562578 |
chr15:35461219-35461220 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs554701132 |
chr15:35461278-35461279 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs149696181 |
chr15:35461394-35461395 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs181824467 |
chr15:35461406-35461407 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs558825309 |
chr15:35461447-35461448 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs556056043 |
chr15:35461450-35461451 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs571123283 |
chr15:35461460-35461461 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs577152336 |
chr15:35461549-35461550 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs544644661 |
chr15:35461574-35461575 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs556613786 |
chr15:35461632-35461633 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs538479404 |
chr15:35461715-35461716 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs200408550 |
chr15:35461727-35461728 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs185965203 |
chr15:35461740-35461741 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs1458885 |
chr15:35461760-35461761 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs560249630 |
chr15:35461771-35461772 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs77612190 |
chr15:35461833-35461834 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs564859472 |
chr15:35461838-35461839 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs551212327 |
chr15:35461853-35461854 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs532100316 |
chr15:35461861-35461862 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs12591832 |
chr15:35461890-35461891 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs562152117 |
chr15:35461930-35461931 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs115389193 |
chr15:35461944-35461945 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs191828167 |
chr15:35461951-35461952 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs371497913 |
chr15:35462013-35462014 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs534162625 |
chr15:35462022-35462023 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs144479353 |
chr15:35462041-35462042 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs4597271 |
chr15:35462142-35462143 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs538352683 |
chr15:35462200-35462201 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs4923920 |
chr15:35462220-35462221 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs139121103 |
chr15:35462222-35462223 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs183172481 |
chr15:35462250-35462251 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs186337688 |
chr15:35462253-35462254 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs372261775 |
chr15:35462262-35462263 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|